Do you want to read an article? Please log in or register.
BASELINE PREDICTORS OF SHORT- AND LONG-TERM CLINICAL REMISSION UNDER MEPOLIZUMAB IN SEVERE EOSINOPHILIC ASTHMA IN REAL-WORLD PRACTICE
Asthma
Related content
Asthma
Long-Term Adherence to Benralizumab and Sustained Clinical Benefits in Patients with Severe Eosinophilic Asthma: Insights from GALERNA, a Retrospective Real-World Study in Spain
J Clin Med
García-Moguel I, Agüero Calvo J, Betancor Pérez D, Carretero Gracia JÁ, Díaz-Campos RM, Fernández Martínez de Septien C, Gómez-Bastero Fernández A, Hernández Galván Y, Lloret-Queraltó JA, Lluch Tortajada I, Malanda NM, Martín-García C, Martínez Mesa Á, Martínez-Moragon E, Medina Gallardo JF, Padilla-Galo A, Pérez Chica G, Plasencia García I, Prieto Montaño P, Puchaes Manchón C, Romero Ribate D, Valverde-Monge M, Zamarro Parra MS, Sanchez-Trincado JL, Nuevo J, Luzon E, Velasco-Garrido JL
doi: 10.3390/jcm15124564
Asthma
Long-Term Clinical and Biological Outcomes of Biologic Therapy in Severe Asthma: 24-Month Real-World Cohort Study from Romania
J Clin Med
Mărginean C, Safta AC, Huțanu D, Budin CE, Ianosi MB, Jimborean G, Ianosi ES
doi: 10.3390/jcm15062444
RECOMMENDED
Asthma
Real-World Effectiveness and Safety of Mepolizumab in Pediatric Severe Eosinophilic Asthma: A Multicenter Study
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Pediatr Pulmonol
Çevik NN, Ocak M, Kocatepe G, Teker NB, Kocacik Uygun DF, Serbes M, Ozcan D, Bingol A, Sekerel BE
doi: 10.1002/ppul.71466
COMMENTED
Asthma
Clinical Remission in Severe Asthma: A Comparative Analysis of Patients with and Without Biologics from the Swiss Severe Asthma Registry
★ 2
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 3
Recommended and commented by
Dr Marcus Hesse, Faculty Member
Biomedicines
Jaun F, Boesing M, Lüthi-Corridori G, Bridevaux PO, Charbonnier F, Clarenbach CF, Fellrath JM, Gianella P, Jochmann A, Kern L, Pavlov N, Latshang TD, Von Garnier C, Leuppi JD
doi: 10.3390/biomedicines13123074
Asthma
Effectiveness of Mepolizumab in Patients with OCS-Dependent Severe Asthma: A Real-World Study
Adv Ther
Bavbek S, Al-Ahmad M, Samaha H, Kathuria PC, Fernandez P, Al Busaidi N, Ibrahim T, Mahboub B, Haider S, Noibi S, Levy G, Al-Lehebi RO
doi: 10.1007/s12325-025-03338-w
Asthma
Time to Rethink ICS Dosing in Pursuit of Asthma Clinical Remission: High-Dose ICS/LABA May Restore Short-Term Asthma Control When Medium Doses Fail
J Clin Med
Kołacińska-Flont M, Kupryś-Lipińska I, Wojakiewicz M, Dębowski T, Kuna P
doi: 10.3390/jcm15145462
Asthma
Impact of Health Insurance Type on Access to Biologics and Systemic Corticosteroid Exposure in Patients With Severe Asthma: A Real-World Study From the Korean Severe Asthma Registry (KoSAR)
Allergy Asthma Immunol Res
Sohn KH, Lee SK, Lee HY, Kim SR, Lee SE, Kim JH, Song WJ, Kim SH, Korean Severe Asthma Registry (KoSAR) Investigators
doi: 10.4168/aair.2026.18.2.192
COMMENTED
Asthma
Long-term efficacy but rare sustained remission: Individual-level five-year stability in anti-IL5/Rα biologic therapy response for severe asthma
★ 3
Recommended and commented by
Dr. med. Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Eur Respir J
Håkansson KEJ, Hansen S, Soendergaard MB, von Bülow A, Hilberg O, Bonnesen B, Johnsen CR, Lock-Johansson S, Dongo L, Borup MB, Vijdea R, Rasmussen LM, Schmid JM, Ulrik CS, Porsbjerg C, Bjerrum AS
doi: 10.1183/13993003.00926-2025
Asthma
Real-World Effectiveness Following Benralizumab Use in Patients with Severe Eosinophilic Asthma in Romania: A Retrospective Cohort Study (BREEZE)
J Clin Med
Toma CL, Teodorescu G, Mihălţan FD, Frent S, Ali S, Trenchea M, Constantin AA
doi: 10.3390/jcm15020425